Manchester Capital Management LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 79 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Manchester Capital Management LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$20,000
-62.3%
14,9840.0%0.00%
-62.5%
Q4 2018$53,000
+29.3%
14,9840.0%0.01%
+33.3%
Q3 2018$41,000
-22.6%
14,9840.0%0.01%
-25.0%
Q2 2018$53,000
+15.2%
14,9840.0%0.01%
+14.3%
Q1 2018$46,000
-51.1%
14,9840.0%0.01%
-50.0%
Q4 2017$94,000
-7.8%
14,9840.0%0.01%
-12.5%
Q3 2017$102,000
-4.7%
14,9840.0%0.02%
-5.9%
Q2 2017$107,000
-22.5%
14,9840.0%0.02%
-22.7%
Q1 2017$138,000
+130.0%
14,9840.0%0.02%
+144.4%
Q4 2016$60,000
+106.9%
14,984
+100.0%
0.01%
+125.0%
Q3 2016$29,000
-9.4%
7,4920.0%0.00%
-20.0%
Q2 2016$32,000
-8.6%
7,4920.0%0.01%0.0%
Q1 2016$35,000
-53.3%
7,4920.0%0.01%
-54.5%
Q4 2015$75,000
+33.9%
7,4920.0%0.01%
+22.2%
Q3 2015$56,000
-84.2%
7,4920.0%0.01%
-83.9%
Q2 2015$355,000
+624.5%
7,492
+66.5%
0.06%
+600.0%
Q1 2014$49,0004,5000.01%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q1 2019
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,048,642$3,219,0000.50%
Virtus ETF Advisers LLC 130,920$402,0000.35%
683 Capital Management, LLC 600,000$1,842,0000.16%
Tekla Capital Management LLC 859,322$2,638,0000.10%
DOW CHEMICAL CO /DE/ 65,000$200,0000.07%
Alambic Investment Management, L.P. 115,834$356,0000.05%
A.R.T. Advisors, LLC 262,896$807,0000.03%
Candriam S.C.A. 520,613$1,598,0000.03%
Man Group plc 1,674,341$5,140,0000.02%
Baker Brothers Advisors 935,000$2,870,0000.02%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders